drugset / Trial / NCT01298973

Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions

NCT01298973 ↗

Phase 4 Completed 50 enrolled Innovative Medical
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to look at the ability of Viscoat to ensure proper wound closure.

Timeline

Start
2011-01
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Viscoat Unknown — —

Indications